Insider Buying: Aerie Pharmaceuticals COO Purchases 5,000 Shares of Stock (AERI)
Aerie Pharmaceuticals (NASDAQ:AERI) COO Thomas Mitro purchased 5,000 shares of the company’s stock on the open market in a transaction dated Wednesday, October 30th. The stock was purchased at an average cost of $10.00 per share, with a total value of $50,000.00. Following the purchase, the chief operating officer now directly owns 5,000 shares of the company’s stock, valued at approximately $50,000. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link.
Aerie Pharmaceuticals (NASDAQ:AERI) remained flat at $10.50 during trading on Friday. The stock had a trading volume of 35,669 shares. The stock has a 50-day moving average of $0. and a 200-day moving average of $0.. The company’s market cap is $10.7 million.
Aerie Pharmaceuticals, Inc is a United States-based company. The Company is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.